Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines
Carl Parson, Valerie Smith, Christopher Krauss, Hirendra N. Banerjee, Christopher Reilly, Jeanette A. Krause, James M. Wachira, Dipak Giri, Angela Winstead, Santosh K. Mandal
Journal of Pharmaceutical Research International · pp. 362–367 · Published 9 Dec 2013
10.9734/BJPR/2014/4697Abstract
Aim: To study the efficacy of novel rhenium compounds to treat triple node negative breast cancer. Study Design: Six (6) novel rhenium pentycarbanato compounds (PC1-6) were synthesized and triple node negative breast cancer cell lines HTB-132 and Balb/c mouse kidney cell lines were treated with each of them for 48 hours. The results were analyzed by a common trypan blue cell death assay system and statistically analyzed. Place and Duration: The compounds were synthesized, analyzed and evaluated at the Department of Chemistryof Morgan State University, Baltimore, Maryland and the Pharmaceutical Sciences Department of Elizabeth City State University campus of the University of North Carolina system. Methodology: The novel rhenium compounds were synthesized from one-pot reactions of Re2(CO)10 with the corresponding α-diimine ligands in 1-pentanol.The compounds were characterized spectroscopically. The cell lines were cultured by standard cell culture procedure and treated with each of the six compounds in DMSO for 48 hours with a negative control and a DMSO vehicular control along with a cisplatin positive control.The cytotoxicity was evaluated by standard trypan blue assay and the results were statistically analyzed. Results: The trypan blueassay reveals that these compounds have significant cytotoxicity against MDA-MB-468 (HTB-132) triple node negative breast cancer cell lines and are less nephrotoxic than cisplatin. Conclusion: The novel rhenium compounds PC 1-6 can potentially find applications in the treatment of highly malignant triple node negative breast cancer.
Cited by 19
P. Collery, Ahmed Mohsen, Anthony Kermagoret · Investigational new drugs · 2015
M. Marques · 2014
J. Medley, G. Payne, H. Banerjee · Molecular and Cellular Biochemistry · 2014
A. Leonidova, G. Gasser · ACS Chemical Biology · 2014
N. Banerjee, K. Mandal, K. Pramanik · 2015
Nuchareenat Wiratpruk, Guneet K. Bindra, Alex Hamilton · Dalton Transactions · 2022
Elisa Palma, Joana F. Santos, Célia Fernandes · Chemistry – A European Journal · 2024
Zehra Hashim, Nida Syed, Amber Ilyas · Current Cancer Drug Targets · 2023
Tamara Petrović, Nevenka Gligorijević, Vesna Medaković · Applied Organometallic Chemistry · 2024
Related research
- Molecular Identification, Bioactivity Screening and Metabolic Fingerprinting of the Actinomycetes of Chenab River Sediments — shares topic coverage
- Antimalarial Efficacy of Bergenia ciliata (Saxifragaceae) Leaf Extract In vitro against Plasmodium falciparum and In vivo against Plasmodium berghei — shares topic coverage
- Anti-viral Activity Evaluation of Selected Medicinal Plants of Nigeria against Measles Virus — shares topic coverage
- In Vitro Antioxidant and In Vivo Antidiabetic Properties of Citrus Maxima Leaf Extracts in Alloxan-Induced Swiss Albino Diabetic Mice — shares topic coverage
- Cytotoxic Effects of Cadmium and Paraquat on Avian Skin Fibroblasts — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
19
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.